Published in J Virol on April 02, 2008
IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling. Genes Dev (2012) 1.20
Identification of a male-specific RNA binding protein that regulates sex-specific splicing of Bmdsx by increasing RNA binding activity of BmPSI. Mol Cell Biol (2010) 1.01
Live cell visualization of the interactions between HIV-1 Gag and the cellular RNA-binding protein Staufen1. Retrovirology (2010) 0.94
The conserved N-terminal basic residues and zinc-finger motifs of HIV-1 nucleocapsid restrict the viral cDNA synthesis during virus formation and maturation. Nucleic Acids Res (2008) 0.89
Expression of IMP1 enhances production of murine leukemia virus vector by facilitating viral genomic RNA packaging. PLoS One (2010) 0.79
HIV-1 and two avian retroviral 5' untranslated regions bind orthologous human and chicken RNA binding proteins. Virology (2015) 0.77
Inhibition of HIV-1 assembly by coiled-coil domain containing protein 8 in human cells. Sci Rep (2015) 0.76
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature (2002) 21.53
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature (2004) 17.56
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother (2002) 13.91
Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell (2001) 12.00
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science (2003) 10.79
Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci U S A (1991) 10.05
Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell (1993) 7.34
p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol (1995) 6.87
Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell (1996) 6.74
AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell (2003) 6.69
Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature (2000) 5.60
A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol (1999) 5.58
RNA packaging. Curr Top Microbiol Immunol (1996) 4.88
Viral late domains. J Virol (2002) 4.51
HIV-1: fifteen proteins and an RNA. Annu Rev Biochem (1998) 4.33
Structural organization of authentic, mature HIV-1 virions and cores. EMBO J (2003) 4.32
Structure of full-length HIV-1 CA: a model for the mature capsid lattice. Cell (2007) 4.25
Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc Natl Acad Sci U S A (2004) 3.90
Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J Virol (2000) 3.77
RNA is a structural element in retrovirus particles. Proc Natl Acad Sci U S A (2001) 3.45
In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J Virol (1999) 3.34
Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology (1997) 3.24
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G. J Biol Chem (2006) 3.03
How retroviruses select their genomes. Nat Rev Microbiol (2005) 2.99
Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: critical role in reverse transcription and molecular mechanism. Prog Nucleic Acid Res Mol Biol (2005) 2.98
Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. J Virol (2007) 2.95
The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag. J Virol (1998) 2.93
NMR structure of the HIV-1 nucleocapsid protein bound to stem-loop SL2 of the psi-RNA packaging signal. Implications for genome recognition. J Mol Biol (2000) 2.89
AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell (2005) 2.68
Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J Virol (1996) 2.65
The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology (2007) 2.54
Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation. J Virol (2007) 2.47
VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins. Biol Cell (2005) 2.41
Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression. J Virol (2001) 2.12
Beyond Tsg101: the role of Alix in 'ESCRTing' HIV-1. Nat Rev Microbiol (2007) 2.08
Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding. J Virol (2007) 2.08
Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain. AIDS Res Hum Retroviruses (1995) 2.01
Human immunodeficiency virus type 1 assembly, release, and maturation. Adv Pharmacol (2007) 1.90
Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag). J Virol (2000) 1.90
The HIV-1 assembly machine. AIDS (2001) 1.88
APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription. J Biol Chem (2007) 1.87
Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation. J Virol (1997) 1.83
The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins. Nucleic Acids Res (1998) 1.82
Molecular composition of IMP1 ribonucleoprotein granules. Mol Cell Proteomics (2007) 1.80
The insulin-like growth factor mRNA binding-protein IMP-1 and the Ras-regulatory protein G3BP associate with tau mRNA and HuD protein in differentiated P19 neuronal cells. J Neurochem (2004) 1.66
A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking. Scand J Clin Lab Invest Suppl (2001) 1.61
Cis-acting determinants of asymmetric, cytoplasmic RNA transport. RNA (2007) 1.60
Three-dimensional structure of the M-MuLV CA protein on a lipid monolayer: a general model for retroviral capsid assembly. EMBO J (2003) 1.58
H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein. J Biol Chem (2000) 1.54
Role of HIV-1 Gag domains in viral assembly. Biochim Biophys Acta (2003) 1.53
The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation. J Virol (2000) 1.50
Human immunodeficiency virus type 1 Gag engages the Bro1 domain of ALIX/AIP1 through the nucleocapsid. J Virol (2007) 1.48
Intracellular trafficking of HIV-1 Gag: how Gag interacts with cell membranes and makes viral particles. AIDS Rev (2005) 1.44
Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant. Mol Cell Biol (2002) 1.43
Incorporation of lysyl-tRNA synthetase into human immunodeficiency virus type 1. J Virol (2001) 1.41
Cytoplasmic trafficking of IGF-II mRNA-binding protein by conserved KH domains. J Cell Sci (2002) 1.38
Association of RNA helicase a with human immunodeficiency virus type 1 particles. J Biol Chem (2006) 1.37
The clathrin adaptor complex AP-1 binds HIV-1 and MLV Gag and facilitates their budding. Mol Biol Cell (2007) 1.30
Myristoylation is required for human immunodeficiency virus type 1 Gag-Gag multimerization in mammalian cells. J Virol (2007) 1.17
Sequences downstream of the 5' splice donor site are required for both packaging and dimerization of human immunodeficiency virus type 1 RNA. J Virol (2003) 1.13
Multifaceted antiviral actions of APOBEC3 cytidine deaminases. Trends Immunol (2006) 1.12
The host protein Staufen1 participates in human immunodeficiency virus type 1 assembly in live cells by influencing pr55Gag multimerization. J Virol (2007) 1.03
HIV-1 Gag: flipped out for PI(4,5)P(2). Proc Natl Acad Sci U S A (2006) 0.97
Opposing effects of the M368A point mutation and deletion of the SP1 region on membrane binding of human immunodeficiency virus type 1 Gag. Virology (2005) 0.90
Critical role of helix 4 of HIV-1 capsid C-terminal domain in interactions with human lysyl-tRNA synthetase. J Biol Chem (2007) 0.89
The R362A mutation at the C-terminus of CA inhibits packaging of human immunodeficiency virus type 1 RNA. Virology (2005) 0.86
IMP1 interacts with poly(A)-binding protein (PABP) and the autoregulatory translational control element of PABP-mRNA through the KH III-IV domain. FEBS J (2006) 0.84
eIF4E--from translation to transformation. Oncogene (2004) 3.78
eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc Natl Acad Sci U S A (2010) 3.13
The IFITM proteins inhibit HIV-1 infection. J Virol (2010) 2.80
The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe (2013) 2.39
Translational control of the innate immune response through IRF-7. Nature (2008) 2.30
Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression. J Virol (2005) 2.02
The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. J Virol (2009) 2.00
An array microscope for ultrarapid virtual slide processing and telepathology. Design, fabrication, and validation study. Hum Pathol (2004) 1.98
IFITM proteins restrict viral membrane hemifusion. PLoS Pathog (2013) 1.86
Development and validation of a novel method to derive central aortic systolic pressure from the radial pressure waveform using an n-point moving average method. J Am Coll Cardiol (2011) 1.85
The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. J Virol (2012) 1.64
Is HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably? Retrovirology (2004) 1.59
p53-dependent translational control of senescence and transformation via 4E-BPs. Cancer Cell (2009) 1.51
Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis. Chem Biol (2008) 1.43
Association of RNA helicase a with human immunodeficiency virus type 1 particles. J Biol Chem (2006) 1.37
Tetherin restricts direct cell-to-cell infection of HIV-1. Retrovirology (2010) 1.34
A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions. J Virol (2004) 1.30
Interactions between metal ions and carbohydrates. Spectroscopic characterization and the topology coordination behavior of erythritol with trivalent lanthanide ions. Inorg Chem (2011) 1.26
Identification of an endocytic signal essential for the antiviral action of IFITM3. Cell Microbiol (2014) 1.23
Fiber-optic confocal reflectance microscope with miniature objective for in vivo imaging of human tissues. IEEE Trans Biomed Eng (2002) 1.23
Mutation of the SP1 sequence impairs both multimerization and membrane-binding activities of human immunodeficiency virus type 1 Gag. J Virol (2005) 1.21
Fiber optic confocal reflectance microscopy: a new real-time technique to view nuclear morphology in cervical squamous epithelium in vivo. Opt Express (2003) 1.21
The blast resistance gene Pi37 encodes a nucleotide binding site leucine-rich repeat protein and is a member of a resistance gene cluster on rice chromosome 1. Genetics (2007) 1.19
The in silico map-based cloning of Pi36, a rice coiled-coil nucleotide-binding site leucine-rich repeat gene that confers race-specific resistance to the blast fungus. Genetics (2007) 1.15
Sequences downstream of the 5' splice donor site are required for both packaging and dimerization of human immunodeficiency virus type 1 RNA. J Virol (2003) 1.13
Surviving lethal septic shock without fluid resuscitation in a rodent model. Surgery (2010) 1.13
The isolation and characterization of Pik, a rice blast resistance gene which emerged after rice domestication. New Phytol (2010) 1.12
Characterization of desnutrin functional domains: critical residues for triacylglycerol hydrolysis in cultured cells. J Lipid Res (2009) 1.11
Comparative homegarden medical ethnobotany of Naxi healers and farmers in Northwestern Yunnan, China. J Ethnobiol Ethnomed (2014) 1.08
Pharmacologic resuscitation promotes survival and attenuates hemorrhage-induced activation of extracellular signal-regulated kinase 1/2. J Surg Res (2010) 1.08
Effect of valproic acid on acute lung injury in a rodent model of intestinal ischemia reperfusion. Resuscitation (2011) 1.07
The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA. Retrovirology (2015) 1.06
Carbon nanotubes promote neuron differentiation from human embryonic stem cells. Biochem Biophys Res Commun (2009) 1.06
The Pik-p resistance to Magnaporthe oryzae in rice is mediated by a pair of closely linked CC-NBS-LRR genes. Theor Appl Genet (2010) 1.05
ABCB6 mutations cause ocular coloboma. Am J Hum Genet (2012) 1.04
In vitro identification and characterization of an early complex linking HIV-1 genomic RNA recognition and Pr55Gag multimerization. J Biol Chem (2004) 1.02
Negative effect of the M184V mutation in HIV-1 reverse transcriptase on initiation of viral DNA synthesis. Virology (2003) 1.02
Microwave plasma enhanced chemical vapor deposition growth of few-walled carbon nanotubes using catalyst derived from an iron-containing block copolymer precursor. Nanotechnology (2008) 1.02
Tetherin inhibits prototypic foamy virus release. Virol J (2011) 1.02
The requirement of the DEAD-box protein DDX24 for the packaging of human immunodeficiency virus type 1 RNA. Virology (2008) 1.02
Coordinate roles of Gag and RNA helicase A in promoting the annealing of formula to HIV-1 RNA. J Virol (2010) 1.01
BST-2 diminishes HIV-1 infectivity. J Virol (2010) 1.00
CT evaluation of cervical pedicle in a Chinese population for surgical application of transpedicular screw placement. Surg Radiol Anat (2008) 0.98
Deficient dimerization of human immunodeficiency virus type 1 RNA caused by mutations of the u5 RNA sequences. Virology (2002) 0.98
Novel frizzled-4 gene mutations in chinese patients with familial exudative vitreoretinopathy. Arch Ophthalmol (2010) 0.98
Substitutions in the reverse transcriptase and protease genes of HIV-1 subtype B in untreated individuals and patients treated with antiretroviral drugs. MedGenMed (2005) 0.97
Traumatic brain injury and hemorrhagic shock: evaluation of different resuscitation strategies in a large animal model of combined insults. Shock (2012) 0.96
The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses. AIDS (2002) 0.95
Hydrogen sulfide regulates cardiac function and structure in adriamycin-induced cardiomyopathy. Circ J (2009) 0.94
Important role for the CA-NC spacer region in the assembly of bovine immunodeficiency virus Gag protein. J Virol (2004) 0.93
Design and evaluation of an ultra-slim objective for in-vivo deep optical biopsy. Opt Express (2010) 0.93
The isolation of Pi1, an allele at the Pik locus which confers broad spectrum resistance to rice blast. Theor Appl Genet (2012) 0.92
The packaging of human immunodeficiency virus type 1 RNA is restricted by overexpression of an RNA helicase DHX30. Virology (2007) 0.92
A novel frame-shift mutation in FRMD7 causes X-linked idiopathic congenital nystagmus in a Chinese family. Mol Vis (2011) 0.91
The identification of Pi50(t), a new member of the rice blast resistance Pi2/Pi9 multigene family. Theor Appl Genet (2012) 0.91
Effects of a single amino acid substitution within the p2 region of human immunodeficiency virus type 1 on packaging of spliced viral RNA. J Virol (2003) 0.91
Pharmacologic resuscitation decreases circulating cytokine-induced neutrophil chemoattractant-1 levels and attenuates hemorrhage-induced acute lung injury. Surgery (2012) 0.91
Multidrug-resistant variants of HIV type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variants. J Infect Dis (2009) 0.91
Effects of Nanoanatase TiO2 on photosynthesis of spinach chloroplasts under different light illumination. Biol Trace Elem Res (2007) 0.90
The MOV10 helicase inhibits LINE-1 mobility. J Biol Chem (2013) 0.90
Opposing effects of the M368A point mutation and deletion of the SP1 region on membrane binding of human immunodeficiency virus type 1 Gag. Virology (2005) 0.90
BMP9-induced osteogenetic differentiation and bone formation of muscle-derived stem cells. J Biomed Biotechnol (2012) 0.90
Platelet activation and dysfunction in a large-animal model of traumatic brain injury and hemorrhage. J Trauma Acute Care Surg (2013) 0.89
Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study. J Surg Res (2013) 0.89
The HIV-1 Vpu viroporin inhibitor BIT225 does not affect Vpu-mediated tetherin antagonism. PLoS One (2011) 0.88
Hemostatic and pharmacologic resuscitation: results of a long-term survival study in a swine polytrauma model. J Trauma (2011) 0.87
Pharmacologic resuscitation for hemorrhagic shock combined with traumatic brain injury. J Trauma Acute Care Surg (2012) 0.87
Tetherin and its viral antagonists. J Neuroimmune Pharmacol (2011) 0.87
HIV-1 Vpr activates both canonical and noncanonical NF-κB pathway by enhancing the phosphorylation of IKKα/β. Virology (2013) 0.86
The R362A mutation at the C-terminus of CA inhibits packaging of human immunodeficiency virus type 1 RNA. Virology (2005) 0.86
A HIV-1 minimal gag protein is superior to nucleocapsid at in vitro annealing and exhibits multimerization-induced inhibition of reverse transcription. J Biol Chem (2005) 0.86
The highly polymorphic cyclophilin A-binding loop in HIV-1 capsid modulates viral resistance to MxB. Retrovirology (2015) 0.86
High-throughput assay to identify inhibitors of Vpu-mediated down-regulation of cell surface BST-2. Antiviral Res (2011) 0.86
Antioxidant stress is promoted by nano-anatase in spinach chloroplasts under UV-B radiation. Biol Trace Elem Res (2007) 0.85
DDX17 promotes the production of infectious HIV-1 particles through modulating viral RNA packaging and translation frameshift. Virology (2013) 0.85
Prevalence of blood alcohol in fatal traffic crashes in Shanghai. Forensic Sci Int (2012) 0.85
Prognostic value of mitochondrial DNA content and G10398A polymorphism in non-small cell lung cancer. Oncol Rep (2013) 0.85
Leptin attenuates cerebral ischemia injury through the promotion of energy metabolism via the PI3K/Akt pathway. J Cereb Blood Flow Metab (2013) 0.85
HIV-1 Vpr stimulates NF-κB and AP-1 signaling by activating TAK1. Retrovirology (2014) 0.84
Characterization of the interface of the bone marrow stromal cell antigen 2-Vpu protein complex via computational chemistry. Biochemistry (2012) 0.84
Poly(methacrylic acid)-grafted carbon nanotube scaffolds enhance differentiation of hESCs into neuronal cells. Adv Mater (2010) 0.84
Influences of calcium deficiency and cerium on growth of spinach plants. Biol Trace Elem Res (2007) 0.83
From promoting to inhibiting: diverse roles of helicases in HIV-1 Replication. Retrovirology (2012) 0.83